Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...

A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.BCG ...

A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.

Bladder cancer can be a silent killer, often presenting few symptoms in its early stages. Learn about the disease, its early symptoms, and more.

When it comes to cancer care, precision isn rsquo;t a luxury mdash;it rsquo;s an essential aspect of the treatment .

BOSTON & MONTREAL, June 25, 2025--enGene Holdings Inc. (Nasdaq: ENGN, or "enGene" or the "Company"), a clinical-stage, non-viral gene-based immunotherapy company, today announced that the U.S. Food ...

HSHS St. John's Hospital is pioneering a new procedure using blue light technology to enhance the detection of bladder cancer ...

A Bridgeport resident says the CT DOC's failure to provide timely treatment led to 28 rounds of chemotherapy and the removal ...

Bladder cancer saw few therapeutic advances for decades until the advent of checkpoint inhibitor therapy with PD-1/PD-L1 inhibitors, ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC).

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

In the neoadjuvant and adjuvant phases of arm C, pembrolizumab will be administered on day 1 and enfortumab vedotin will be administered on days 1 and 8 of each cycle. Enrollment is complete for arm A ...